Idi na sadržaj

Otolaringologija – kirurgija glave i vrata

Transfuzija – rizici i neizvjesnost

Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. (otvara se novi prozor)

Bhide SA, Ahmed M, Rengarajan V, Powell C, Miah A, Newbold K, Nutting CM, Harrington KJ.

Izvor‎: Int J Radiat Oncol Biol Phys 2009;73(2):391-8.

Indeks‎: PubMed 18692326

DOI‎: 10.1016/j.ijrobp.2008.04.052

https://www.ncbi.nlm.nih.gov/pubmed/18692326 (otvara se novi prozor)

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy?—results from the randomized DAHANCA 5 and 7 trials. (otvara se novi prozor)

Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J.

Izvor‎: Acta Oncol 2011;50(7):1006-14.

Indeks‎: PubMed 21790306

DOI‎: 10.3109/0284186X.2011.592650

https://www.ncbi.nlm.nih.gov/pubmed/21790306 (otvara se novi prozor)

Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery. (otvara se novi prozor)

Perisanidis C, Dettke M, Papadogeorgakis N, Schoppmann A, Mittlböck M, Kyzas PA, Ewers R, Seemann R.

Izvor‎: Oral Oncol 2012;48(4):372-8.

Indeks‎: PubMed 22182932

DOI‎: 10.1016/j.oraloncology.2011.11.020

https://www.ncbi.nlm.nih.gov/pubmed/22182932 (otvara se novi prozor)